<DOC>
	<DOCNO>NCT02430896</DOCNO>
	<brief_summary>The objective study identification neuropsychological , genetic neuroimaging marker treatment response predictor attention-deficit/hyperactivity disorder ( ADHD ) . Participants take standardize pharmacotherapy ( methylphenidate atomoxetine ) ADHD observe 52 week . They several neuropsychological , neuroimaging genetic test visit 1~6 .</brief_summary>
	<brief_title>Identification Neuropsychological , Genetic Neuroimaging Markers Treatment Response Predictors ADHD</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>1. age 6 12 year 2. meet Diagnostic Statistical Manual IV Text Revision ( DSMIVTR ) diagnostic criterion ADHD need pharmacotherapy . 3 . Informed consent 1. presence intellectual disability learn disorder 2. past and/or current history bipolar disorder psychosis substance use disorder 3. past and/or current history pervasive developmental disorder , organic mental disorder neurological disorder 4. presence sever suicidal ideation 5. presence tic disorder obsessivecompulsive disorder whose symptom need pharmacotherapy 6. presence family history Tourette 's Syndrome 7. take medication methylphenidate atomoxetine last 6 month ( 3 month ) 8. presence severe medical condition ( ex . cardiologic , liver , kidney , pulmonary , glaucoma ) 9. take alpha 2 adrenergic receptor agonist , antidepressant , antipsychotic , benzodiazepine , modafinil , antiepileptic drug dietary supplement influence Central Nervous System ( CNS ) . 10. presence possibility pregnancy 11. especially neuroimaging , 1. uncooperative claustrophobia body movement 2. metal material inside body ca n't take</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Neuropsychological</keyword>
	<keyword>neuroimaging</keyword>
	<keyword>genetic marker</keyword>
	<keyword>treatment response predictor</keyword>
</DOC>